Incyte (INCY)
115.71
-1.22 (1.04%)
Upcoming Events
Latest Headlines
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
October 24, 2026 7:00 AM - BizWire
Incyte (INCY) PT Raised to $140 at TD Cowen
October 21, 2026 8:12 AM - StreetInsider
Morgan Stanley Assumes Incyte (INCY) at Equalweight
October 20, 2026 3:08 AM - StreetInsider
Form 4 INCYTE CORP For: Oct 15 Filed by: CAGNONI PABLO J
October 19, 2026 4:38 PM - SEC Filing
Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
October 18, 2026 6:05 PM - BizWire
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
October 16, 2026 6:49 AM - StreetInsider
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
October 15, 2026 4:01 PM - SEC Filing
Incyte (INCY) PT Raised to $115 at Truist Securities
October 14, 2026 7:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
October 13, 2026 6:46 AM - StreetInsider
Incyte to Report Third Quarter Financial Results
October 8, 2026 8:00 AM - BizWire
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
October 6, 2026 7:35 AM - Globe NewsWire
Form 4 INCYTE CORP For: Oct 01 Filed by: Heeson Lee
October 5, 2026 4:02 PM - SEC Filing
Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained
October 5, 2026 9:29 AM - StreetInsider
Incyte (INCY) PT Raised to $157 at Stifel
October 5, 2026 5:28 AM - StreetInsider
Form 4 INCYTE CORP For: Sep 30 Filed by: Baker Brothers Life Sciences LP
October 2, 2026 5:55 PM - SEC Filing
Form 4 INCYTE CORP For: Sep 30 Filed by: Clancy Paul J
October 2, 2026 4:03 PM - SEC Filing
Form 4 INCYTE CORP For: Sep 30 Filed by: HARRIGAN EDMUND
October 2, 2026 4:02 PM - SEC Filing
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
September 28, 2026 9:03 AM - PR NewsWire
Incyte (INCY) PT Raised to $123 at JPMorgan
September 28, 2026 8:38 AM - StreetInsider
Incyte (INCY) PT Raised to $152 at H.C. Wainwright
September 28, 2026 6:55 AM - StreetInsider
FDA approves Atebrioz for rare bone-forming disease in patients 12 and up
September 25, 2026 7:00 PM - StreetInsider
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
September 25, 2026 7:00 PM - BizWire
Form 4 INCYTE CORP For: Sep 22 Filed by: Gardner David H
September 24, 2026 4:06 PM - SEC Filing
Incyte to present skin disease data at EADV congress in Vienna
September 22, 2026 8:31 AM - StreetInsider
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
September 22, 2026 8:30 AM - BizWire
Incyte and Specialised Therapeutics to bring ruxolitinib cream to Australia
September 20, 2026 4:00 PM - StreetInsider
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
September 20, 2026 4:00 PM - PR NewsWire
Form 4 INCYTE CORP For: Sep 15 Filed by: CAGNONI PABLO J
September 17, 2026 4:05 PM - SEC Filing
Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald as Opzelura Attractive in HS
September 16, 2026 7:23 AM - StreetInsider
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
September 15, 2026 4:06 PM - SEC Filing
Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat
September 11, 2026 7:24 AM - StreetInsider
Incyte to Present at Upcoming Investor Conferences
September 1, 2026 8:00 AM - BizWire
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
September 1, 2026 7:12 AM - StreetInsider
BMO Capital Reiterates Market Perform Rating on Incyte (INCY)
September 1, 2026 4:02 AM - StreetInsider
Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil
August 27, 2026 6:00 PM - Globe NewsWire
Form 4 INCYTE CORP For: Aug 25 Filed by: Basi Ramitpal K
August 27, 2026 4:07 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
August 27, 2026 7:06 AM - StreetInsider
TD Cowen Assumes Incyte (INCY) at Buy
August 22, 2026 7:54 AM - StreetInsider
Form 4 INCYTE CORP For: Aug 19 Filed by: CAGNONI PABLO J
August 20, 2026 5:15 PM - SEC Filing
Canaccord Starts Incyte (INCY) at Buy
August 20, 2026 7:16 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
August 20, 2026 6:52 AM - StreetInsider
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
August 19, 2026 4:20 PM - SEC Filing
Incyte (INCY) PT Raised to $130 at Piper Sandler
August 17, 2026 7:43 AM - StreetInsider
Form 4 INCYTE CORP For: Aug 12 Filed by: CAGNONI PABLO J
August 14, 2026 4:03 PM - SEC Filing
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
August 12, 2026 4:09 PM - SEC Filing
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:30 PM - BizWire
Form 4 INCYTE CORP For: Aug 05 Filed by: CAGNONI PABLO J
August 7, 2026 4:04 PM - SEC Filing
Form 4 INCYTE CORP For: Aug 05 Filed by: Mayes Patrick A
August 7, 2026 4:03 PM - SEC Filing
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
August 5, 2026 4:19 PM - SEC Filing
Form 144 INCYTE CORP Filed by: Mayes Patrick A
August 5, 2026 4:18 PM - SEC Filing
Form 4 INCYTE CORP For: Jul 31 Filed by: CAGNONI PABLO J
August 4, 2026 4:04 PM - SEC Filing
Form 4 INCYTE CORP For: Jul 31 Filed by: Mayes Patrick A
August 4, 2026 4:04 PM - SEC Filing
Incyte (INCY) PT Raised to $137 at Mizuho
August 4, 2026 6:39 AM - StreetInsider
Form 144 INCYTE CORP Filed by: Mayes Patrick A
August 3, 2026 4:40 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
August 3, 2026 6:54 AM - StreetInsider
New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS
August 2, 2026 10:01 AM - PR NewsWire
Form 144 INCYTE CORP Filed by: Mayes Patrick A
July 31, 2026 5:00 PM - SEC Filing
Form 144 INCYTE CORP Filed by: CAGNONI PABLO J
July 31, 2026 4:05 PM - SEC Filing
Incyte (INCY) PT Raised to $120 at JPMorgan
July 30, 2026 9:02 AM - StreetInsider
Incyte (INCY) PT Raised to $119 at Morgan Stanley
July 29, 2026 8:55 AM - StreetInsider
Incyte (INCY) PT Raised to $116 at Wells Fargo
July 29, 2026 8:13 AM - StreetInsider
Incyte (INCY) PT Raised to $130 at BMO Capital
July 29, 2026 7:14 AM - StreetInsider
Incyte (INCY) PT Raised to $150 at Guggenheim
July 29, 2026 7:14 AM - StreetInsider
Incyte (INCY) PT Raised to $150 at H.C. Wainwright
July 29, 2026 6:48 AM - StreetInsider
Incyte (INCY) PT Raised to $109 at RBC Capital
July 29, 2026 6:21 AM - StreetInsider
EU approves Incyte's Opzelura cream for moderate atopic dermatitis
July 29, 2026 6:01 AM - StreetInsider
Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
July 29, 2026 6:00 AM - BizWire
Incyte (INCY) PT Raised to $139 at Barclays
July 29, 2026 5:20 AM - StreetInsider
Form 10-Q INCYTE CORP For: Jun 30
July 28, 2026 4:02 PM - SEC Filing
Incyte (INCY) PT Raised to $120 at Oppenheimer
July 28, 2026 1:38 PM - StreetInsider
Incyte (INCY) Tops Q2 EPS by 110c ; Offers Guidance
July 28, 2026 7:04 AM - StreetInsider
Form 8-K INCYTE CORP For: Jul 28
July 28, 2026 7:02 AM - SEC Filing
Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates
July 28, 2026 7:00 AM - BizWire
Form 4 INCYTE CORP For: Jul 23 Filed by: Morrissey Michael James
July 27, 2026 6:24 PM - SEC Filing
Form 4 INCYTE CORP For: Jul 23 Filed by: Heeson Lee
July 27, 2026 6:23 PM - SEC Filing
Full Article List
